Market Research Future published a research report on Global Cystic Acne Market. Report gives a clear picture of current market scenario which includes past and estimated future market size. The report provides detail information and strategies of top key players in the industry. The report also gives a broad study about different markets segments and regions.
The global cystic acne market is rising with a swift pace; mainly owing to increase in patient population. According to American Academy of Dermatology, in 2015, 60,000,000 Americans have active acne and around 20,000,000 have acne badly enough to cause scars. Increasing consumer awareness about the benefits associated with disposal cystic acne, increasing the demands globally. The factors that cause cystic acne are too much oil produce in the glands of the skin and growth of bacteria called P. acnes. Moreover, advancing technology in healthcare is adding fuel to the growth of the market.
Companies are continuously inventing new products to capture the market globally. Thus, major players and well known professor involve in research and development activity, in order to lead the global market and introduce better treatment. In this regards, Leon H. Kircik, M.D., clinical associate professor of dermatology at Indiana University School of Medicine, recent research on severe and moderate acne patients with inflammatory acne helps to confirm the strength and efficacy of fixed dose combination gel adapalene/benzoyl peroxide 0.3%/2.5%. Companies are investing more into research and development in order to develop quality and advance products, which help them to lead the global market.
Get Sample PDF Illustration @ https://www.marketresearchfuture.com/sample_request/1723
Also stats shows that people are not considering cystic acne a serious issue or they are not aware about the treatment. As per the American Academy of dermatology, in 2015, it is estimated that around 40% of people with acne do nothing about it. Also according to Society for Investigative Dermatology, in 2015, 92% of patients suffering with acne have felt depressed. Companies are more focus to capture the market.
According to the National Center for Biotechnology Information, in 2015, around 9.4% of the global population are affected with acne, and making it the eighth most prevalent disease worldwide.
Regional Analysis for Global Cystic Acne Market
The market of the cystic acne is much higher in the Americas region due to well develop technology and increasing population base. According to the American Academy of Dermatology Association, around 50 million Americans get affected annually with acne, and it is the most common skin condition in the Americas. Also, major players in this market have their focus to capture the huge share of emerging markets such as India and China. According to American Academy of Dermatology Association, in 2016 the costs associated with the treatment of acne exceed $3 billion
Europe is also considering the huge market for cystic acne market, owing to government support for research & development and availability of funds for research. Additionally, Government is more focused to educate their public in order to minimize the patient population.
Asia Pacific and the Middle East and Africa region are considering the big market. Whereas, countries like India and China of Asia Pacific region are considering fastest growing region due to the presence of rapidly huge patient population, and high healthcare expenditure. Additionally, countries from this region looking forward to adopt advanced technology and treatment from developed nation in order to improve the quality of life for their citizen. Whereas the Middle East and Africa are the low market due to his incapability of investment.
Key Players for Global Cystic Acne Market
Some of the key players in this market are GlaxoSmithKline plc (U.K), Pfizer Inc. (U.S.), Abbott Laboratories (U.S.), Hexal AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Alma Lasers Inc. (Israel), Bristol-Myers Squibb Company (U.S.), GE Healthcare (U.K), National Biological Corp. (U.S.), Herbert Waldmann GmbH & Co. KG (Germany), Sylvan Company (U.S.), and DUSA Pharmaceuticals Inc. (U.S.)
Segments for Global Cystic Acne Market
The global cystic acne market is segmented on the basis of causes, long-term effects, treatment type, and end user.
On the basis of the causes, it is segmented into hormonal imbalances, occlusive skin products, drugs/chemical side effects, and others, on the basis of the long-term effects, it is segmented into ice pick scars, larger pits on the skin, shallow depressions, hypertrophic scarring, and others, on the basis of the treatment type, it is segmented into topical medications, drainage & extraction procedure, laser therapy, microdermabrasion, and others and on the basis of the end user, it is segmented into hospitals, clinics, research laboratories, and others.
Some Brief Table of Contents of Report
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Cystic Acne Market, By Causes
Chapter 7. Global Cystic Acne Market, By Long Term Effects
Chapter 8. Global Cystic Acne Market, By Treatment Type
Chapter 9. Global Cystic Acne Market, By End User
Chapter 9. Global Cystic Acne Market, By Region
Chapter 10. Company Landscape
Chapter 11. Company Profiles
Chapter 12. MRFR Conclusion
Chapter 13. Appendix
Get Prime Discount on Report @ https://www.marketresearchfuture.com/check-discount/1723
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Hadapsar, Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
